| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $2.5M | -7.8% |
| SG&A Expense | $8.3M | +30.4% |
| Operating Income | -$8.9M | -5.9% |
| Pre-tax Income | -$9.1M | +15.2% |
| Net Income | -$9.1M | +15.2% |
| EPS (Basic) | -$0.48 | +46.7% |
| EPS (Diluted) | -$0.48 | +46.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | +136.4% |
| Accounts Receivable | $1.3M | +807.5% |
| Current Assets | $5.8M | +176.6% |
| Total Assets | $8.7M | +80.0% |
| Current Liabilities | $2.4M | -2.1% |
| Total Liabilities | $3.6M | +32.6% |
| Stockholders' Equity | $5.0M | +142.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.7M | -93.5% |
| Capital Expenditures | $34K | -73.7% |
| Investing Cash Flow | -$768K | -50.0% |
| Financing Cash Flow | $9.3M | +53.6% |
| Free Cash Flow | -$6.7M | -87.5% |